Exploring the origins of structure–oxygen affinity relationship of human haemoglobin allosteric effector

References

• Sun K, Xia Y. New insights into sickle cell disease: a disease of hypoxia. Curr Opin Hematol. 2013;20:215–221.
   PubMed Web of Science ®Google Scholar
• Rundqvist H, Johnson RS. Tumour oxygenation: implications for breast cancer prognosis. J Int Med. 2013;274:105–112.
   PubMed Web of Science ®Google Scholar
• Lenihan CR, Taylor CT. The impact of hypoxia on cell death pathways. Biochem Soc Trans. 2013;41:657–663.
   PubMed Web of Science ®Google Scholar
• Voelkel NF, Mizuno S, Bogaard HJ. The role of hypoxia in pulmonary vascular diseases: a perspective. Am J Physiol Lung Cell Mol Physiol. 2013;304:L457–L465.
   PubMed Web of Science ®Google Scholar
• Papassotiriou I, Kister J, Griffon N, Abraham DJ, Kanavakis E, Traeger-Synodinos J, Stamoulakatou A, Marden MC, Poyart C. Synthesized allosteric effectors of the hemoglobin molecule: a possible mechanism for improved erythrocyte oxygen release capability in hemoglobinopathy H disease. Exp Hematol. 1998;26:922–926.
   PubMed Web of Science ®Google Scholar
• Mairbaurl H, Weber RE. Oxygen transport by hemoglobin. Compr Physiol. 2012;2:1463–1489.
   PubMed Web of Science ®Google Scholar
• Crawford JH, Chacko BK, Kevil CG, Patel RP. The red blood cell and vascular function in health and disease. Antioxid Redox Signal. 2004;6:992–999.
   PubMed Web of Science ®Google Scholar
• Lalezari I, Lalezari P, Poyart C, Marden M, Kister J, Bohn B, Fermi G, Perutz MF. New effectors of human hemoglobin: structure and function. Biochemistry. 1990;29:1515–1523.
   PubMed Web of Science ®Google Scholar
• Perutz MF, Fermi G, Luisi B, Shaanan B, Liddington RC. Stereochemistry of cooperative mechanisms in hemoglobin. Acc Chem Res. 1987;20:309–321.
   Web of Science ®Google Scholar
• Safo MK, Bruno S. Allosteric effectors of hemoglobin: past, present and future. Chemistry and biochemistry of oxygen therapeutics: from transfusion to artificial blood. West Sussex: John Wiley & Sons, Ltd.; 2011.
   Google Scholar
• Arnone A. X-ray diffraction study of binding of 2,3-diphosphoglycerate to human deoxyhaemoglobin. Nature. 1972;237:146–149.
   PubMed Web of Science ®Google Scholar
• Koumbis AE, Duarte CD, Nicolau C, Lehn JM. Tetrakisphosphates and bispyrophosphates of myo-inositol derivatives as allosteric effectors of human hemoglobin: synthesis, molecular recognition, and oxygen release. ChemMedChem. 2011;6:169–180.
   PubMed Web of Science ®Google Scholar
• Randad RS, Mahran MA, Mehanna AS, Abraham DJ. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure–allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem. 1991;34:752–757.
   PubMed Web of Science ®Google Scholar
• Yonetani T, Park SI, Tsuneshige A, Imai K, Kanaori K. Global allostery model of hemoglobin. Modulation of O(2) affinity, cooperativity, and Bohr effect by heterotropic allosteric effectors. J Biol Chem. 2002;277:34508–34520.
   PubMed Web of Science ®Google Scholar
• Teisseire BP, Ropars C, Vallez MO, Herigault RA, Nicolau C. Physiological effects of high-P50 erythrocyte transfusion on piglets. J Appl Physiol. 1985;8:1810–1817.
   Google Scholar
• Fylaktakidou KC, Lehn JM, Greferath R, Nicolau C. Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin. Bioorg Med Chem Lett. 2005;15:1605–1608.
   PubMed Web of Science ®Google Scholar
• Kieda C, Greferath R, Crola da Silva C, Fylaktakidou KC, Lehn JM, Nicolau C. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes. Proc Natl Acad Sci USA. 2006;103:15576–15581.
   PubMed Web of Science ®Google Scholar
• Biolo A, Greferath R, Siwik DA, Qin F, Valsky E, Fylaktakidou KC, Pothukanuri S, Duarte CD, Schwarz RP, Lehn JM, Nicolau C, Colucci WS. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate. Proc Natl Acad Sci USA. 2009;106:1926–1929.
   PubMed Web of Science ®Google Scholar
• Sihn G, Walter T, Klein JC, Queguiner I, Iwao H, Nicolau C, Lehn JM, Corvol P, Gasc JM. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma. FEBS Lett. 2007;581:962–966.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Isarankura-Na-Ayudhya C, Naenna T, Prachayasittikul V. A practical overview of quantitative structure–activity relationship. Excli J. 2009;8:74–88.
   Web of Science ®Google Scholar
• Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V. Advances in computational methods to predict the biological activity of compounds. Exp Opin Drug Discov. 2010;5:633–654.
   PubMed Web of Science ®Google Scholar
• Mandi P, Nantasenamat C, Srungboonmee K, Isarankura-Na-Ayudhya C, Prachayasittikul V. QSAR study of anti-prion activity of 2-aminothiazoles. Excli J. 2012;11:453–467.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Isarankura-Na-Ayudhya C, Naenna T, Prachayasittikul V. Prediction of bond dissociation enthalpy of antioxidant phenols by support vector machine. J Mol Graph Model. 2008;27:188–196.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Piacham T, Tantimongcolwat T, Naenna T, Isarankura-Na-Ayudhya C, Prachayasittikul V. QSAR model of the quorum-quenching N-acyl-homoserine lactone lactonase activity. J Biol Syst. 2008;16:279–293.
   Web of Science ®Google Scholar
• Thippakorn C, Suksrichavalit T, Nantasenamat C, Tantimongcolwat T, Isarankura-Na-Ayudhya C, Naenna T, Prachayasittikul V. Modeling the LPS neutralization activity of anti-endotoxins. Molecules. 2009;14:1869–1888.
   PubMed Web of Science ®Google Scholar
• Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul S, Prachayasittikul V. Predicting the free radical scavenging activity of curcumin derivatives. Chemometr Intell Lab Syst. 2011;109:207–216.
   Web of Science ®Google Scholar
• Worachartcheewan A, Nantasenamat C, Naenna T, Isarankura-Na-Ayudhya C, Prachayasittikul V. Modeling the activity of furin inhibitors using artificial neural network. Eur J Med Chem. 2009;44:1664–1673.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Isarankura-Na-Ayudhya C, Naenna T, Prachayasittikul V. Quantitative structure–imprinting factor relationship of molecularly imprinted polymers. Biosens Bioelectron. 2007;22:3309–3317.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Isarankura-Na-Ayudhya C, Tansila N, Naenna T, Prachayasittikul V. Prediction of GFP spectral properties using artificial neural network. J Comput Chem. 2007;28:1275–1289.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Naenna T, Isarankura Na Ayudhya C, Prachayasittikul V. Quantitative prediction of imprinting factor of molecularly imprinted polymers by artificial neural network. J Comput Aided Mol Des. 2005;19:509–524.
   PubMed Web of Science ®Google Scholar
• Nantasenamat C, Srungboonmee K, Jamsak S, Tansila N, Isarankura-Na-Ayudhya C, Prachayasittikul V. Quantitative structure–property relationship study of spectral properties of green fluorescent protein with support vector machine. Chemometr Intell Lab Syst. 2013;120:42–52.
   Web of Science ®Google Scholar
• Hansch C, Garg R, Kurup A, Mekapati SB. Allosteric interactions and QSAR: on the role of ligand hydrophobicity. Bioorg Med Chem. 2003;11:2075–2084.
   PubMed Web of Science ®Google Scholar
• ChemAxon Ltd. MarvinSketch, Version 6.2.1. Budapest: ChemAxon Ltd; 2014.
   Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam NJ, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian 09. Revision A.1. Connecticut; 2009.
   Google Scholar
• Talete srl. DRAGON for Windows (Software for Molecular Descriptor Calculations), Version 5.5. Milano; 2007.
   Google Scholar
• Whitley DC, Ford MG, Livingstone DJ. Unsupervised forward selection: a method for eliminating redundant variables. J Chem Inf Comput Sci. 2000;40:1160–1168.
   PubMedGoogle Scholar
• IBM Corporation. SPSS Statistics, Version 18. New York; 2011.
   Google Scholar
• Kennard RW, Stone LA. Computer aided design of experiments. Technometrics. 1969;11:137–148.
   Web of Science ®Google Scholar
• Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20:273–297.
   Web of Science ®Google Scholar
• Vapnik VN. Statistical learning theory. New York: Wiley-Interscience; 1998.
   Google Scholar
• Witten IH, Frank E, Hall MA. Data mining: practical machine learning tools and techniques. 3rd ed. Massachusetts: Morgan Kaufmann Publishers Inc.; 2005.
   Google Scholar
• Rücker C, Rücker G, Meringer M. y-Randomization and its variants in QSPR/QSAR. J Chem Inf Model. 2007;47:2345–2357.
   PubMed Web of Science ®Google Scholar
• Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299–314.
   Google Scholar
• Roy K, Chakraborty P, Mitra I, Ojha PK, Kar S, Das RN. Some case studies on application of “” metrics for judging quality of quantitative structure–activity relationship predictions: emphasis on scaling of response data. J Comput Chem. 2013;34:1071–1082.
   PubMed Web of Science ®Google Scholar
• Lê S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1–18.
   Web of Science ®Google Scholar
• Nadolny C, Kempf I, Zundel G. Specific interactions of the allosteric effector 2,3-bisphosphoglycerate with human hemoglobin – a difference FTIR study. Biol Chem Hoppe Seyler. 1993;374:403–407.
   PubMed Web of Science ®Google Scholar
• Eriksson L, Johansson E. Multivariate design and modeling in QSAR. Chemometr Intell Lab Syst. 1996;34:1–19.
   Web of Science ®Google Scholar